Cash-pay compounded GLP-1 plans

Boston Medical Group review

Boston Medical Group’s current store is useful for comparing complete plan prices: semaglutide starts at $190 for one month, and tirzepatide at $239. The lowest monthly equivalents require twelve-month selections. I would resolve the supplied preparation and a conflict in the shipping information before choosing a long renewal term.

Check your care options.

Confirm the medication, clinical access and recurring bill for your own plan.

Visit Boston Medical GroupOfficial provider website. No affiliate relationship is currently listed.

A fit for

Cash-pay readers who want visible plan totals and will confirm the actual compound, supply schedule, renewal and dispensing conditions.

  • Selected plans show total prices and matching renewal intervals.
  • Medication, care, supplies and shipping are described together.
  • FAQ explains pharmacy choice and billing at shipment.

Tradeoffs to understand

People expecting the lowest equivalent as a flexible monthly bill, proven brand-equivalent outcomes or a refundable prescription after carrier handoff.

  • The four-week medication label persists on longer selections and needs supply clarification.
  • Generic non-refrigerated shipping language conflicts with the GLP storage answer.
  • Full formulation, prescription-specific terms and financial remedies need confirmation.
In this review

The plan total is clearer than the smallest equivalent

The current semaglutide selections show $190 for one month, $399 for three, $714 for six and $1,188 for twelve. Tirzepatide instead shows $239, $589, $1,074 and $1,788 for those terms. The displayed twelve-month equivalents of $99 and $149 are attached to longer commitments, not the one-month offers. Renewal wording changes to the selected one-, three-, six- or twelve-month interval. [1]

FAQ says medication is billed when shipped. Confirm the exact charge and shipment schedule for the selected term: the page’s four-weeks-of-medication label remains visible even on longer selections. It does not establish how many vials arrive together, whether future supplies are separate, or the concentration and full formulation. A clear total still needs a clear supply agreement. [1] [2]

Do not carry the older explanatory page’s claims into the order

The separate SlimFitRx explanation contains older approval language and describes salt-form semaglutide, vitamin additions and brand-like outcomes. That page does not establish what the current prescription actually contains. Ask for the exact active ingredient, complete formula, concentration and dispenser before treating a familiar medication name as sufficient detail. [5]

FDA distinguishes semaglutide salts from the ingredient used in approved drugs and says it is not aware of a lawful compounding basis for those salts. Compounded drugs also do not undergo FDA premarket review. This is a reason to resolve the actual preparation, not proof that every current Boston Medical Group order contains a salt or produces a particular result. [6]

The storage and shipping statements need reconciliation

The GLP product answer says the medicine should be refrigerated between uses. The general returns page instead says the company does not currently ship refrigerated products and that transit delays will not affect them. Those statements do not provide a dependable, preparation-specific shipping agreement. Obtain the current dispenser’s instructions and the process for reporting a questionable shipment. [1] [3]

FDA recommends not using injectable GLP-1 medicine that arrives warm or inadequately refrigerated. A generic shipping reassurance is not personal clearance for such a delivery. Ask the dispenser to address the actual package and medicine rather than assume that a site-wide returns paragraph establishes its quality. [6]

A future cancellation is not a shipped-prescription refund

The product renews at the chosen interval. FAQ says patients are contacted before refill and billing and can cancel through the account. The returns policy refers to cancellation before shipment, then makes prescription sales final once payment has been charged and the package handed to the carrier. Confirm the next renewal and current order status; a general cancel-anytime answer does not promise a partial-term refund. [1] [2] [3]

The policy asks readers to report damage and says lost orders will be reshipped after attempts to locate or redirect them. It does not clearly establish a universal cash remedy, refund for every delay or a physician-nonapproval refund timetable. Payment itself does not guarantee a prescription under the marketplace disclosure. Obtain the selected financial terms before paying. [3] [4]

Evaluate the actual care and dispensing relationship

The store describes medication, consultations, supplies, educational access and ongoing messaging within the service. That does not establish private dietitian visits, an included complete lab panel or a fixed live follow-up schedule. The 24-hour medical-review description is a stated target; some states require live contact, and therapy-specific restrictions apply. [1] [2]

The marketplace does not itself treat or dispense. FAQ names Manifest Pharmacy and RX Compounding Store as possible pharmacies, and terms allow a local-pharmacy request before ordering without guaranteeing its price. These statements do not independently verify the clinician, license, actual dispenser or batch assigned to an individual. My shortlist decision would depend on those specifics and an affordable term. [2] [4]

Understanding the cost

Semaglutide selected totals for one/three/six/twelve months: $190/$399/$714/$1,188. Tirzepatide: $239/$589/$1,074/$1,788. Each renews at its selected interval. FAQ says medication is billed when shipped. Confirm supply, shipment cadence and complete selected charge; lowest equivalents require twelve-month terms. [1] [2]

Build your cost estimate

Sources

  1. Boston Medical Group: selected semaglutide and tirzepatide plans
  2. Boston Medical Group: billing, pharmacy, state and cancellation answers
  3. Boston Medical Group: prescription returns, carrier handoff and loss policy
  4. Boston Medical Group: served terms last updated October 26, 2023
  5. Boston Medical Group: separate SlimFitRx explanatory page
  6. FDA: concerns with unapproved GLP-1 drugs, shipping and salt forms

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.